Company / Return on Assets (ROA)
Emergent BioSolutions Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
4.0%
FY2025
5-year range
-41.7% / 7.4%
FY2021-FY2025
Trend
+129.1%
vs FY2024
Sector context
#40 of 213
Health Care
What the data says
Emergent BioSolutions Inc.'s return on assets (roa) of 4.0% is higher than 81% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -41.7% in FY2023 to 10.6% in FY2020.
Based on SEC 10-K filings.
4.0% in FY2025 with a 5-year CAGR of -6.6%. Top quartile in the Health Care sector.
Improved from -41.7% to 4.0% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +10.7pp
- 5-Year Change
- -6.6pp
- 10-Year Change
- -
Sector benchmark
+116.5% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 129.1% year-over-year.
- Currently 28.1pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 4.0% | +129.1% |
| FY2024 | -13.7% | +67.1% |
| FY2023 | -41.7% | -524.4% |
| FY2022 | -6.7% | -190.0% |
| FY2021 | 7.4% | -29.9% |
| FY2020 | 10.6% | +352.1% |
| FY2019 | 2.3% | +0.9% |
| FY2018 | 2.3% | -69.9% |
| FY2017 | 7.7% | +44.6% |
| FY2016 | 5.3% | -11.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026